Companies: 10,795·Total market cap: $144.5T
LivaNova PLC

LivaNova PLC

LIVNNASDAQHealthcare● Active
$74.31
+$1.95(+2.69%)
Market Cap$4.1B
P/E Ratio
52W High$75.815
52W Low$41.015

LivaNova PLC (LIVN) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

LIVN · free cash flow · updated Jun 8, 2026

Core FCF metrics

Free cash flow was $173.2M for FY2025 (fiscal year ending 2025-12-31), up 27.4% year-over-year The FCF margin was 12.5%.

FY2025 Free Cash Flow$173.2M▲ +27.4% YoY
Trailing 12M (TTM)$161.1Mtrailing 4 quarters sum
FCF Margin12.5%$173.2M ÷ revenue
3-Year CAGR+58.6%FY2022 → FY2025
5-Year CAGRN/AN/A — contains negative FCF
FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0
Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

Positive FCFNegative FCF
Free Cash Flow
YoY Growth %
livn free cash flow history · livn free cash flow chart · livn free cash flow growth rate · livn free cash flow last 10 years

Annual free cash flow data

Fiscal YearFree Cash FlowYoY ChangeFCF Margin
FY2025Latest$173.2M▲ +27.4%12.5%
FY2024$135.9M▲ +240.4%10.8%
FY2023$39.9M▼ 8.0%3.5%
FY2022$43.4M▼ 43.7%4.3%
FY2021$77.1M▲ +167.4%7.4%
FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP
livn free cash flow 2025 · livn free cash flow 2024 · livn free cash flow 2023 · livn operating cash flow

FCF valuation metrics

LivaNova PLC (LIVN) trades at a FCF yield of 3.94% and a price-to-free-cash-flow ratio of 25.1x. FCF per share stands at $2.96, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)
3.94%
Free Cash Flow ÷ Market Cap
per FMP freeCashFlowYieldTTM definition
FCF per Share (TTM)
$2.96
TTM FCF ÷ Shares Outstanding
Price / FCF
x25.1
Share Price ÷ FCF per Share
EV / FCF (TTM)
x24.1
Enterprise Value basis
Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31
livn price to free cash flow · livn free cash flow yield · livn free cash flow per share · livn price to cash flow ratio

Cash flow statement summary

For FY2025, LivaNova PLC generated $254.3M in operating cash flow and spent 81M in capital expenditures, yielding $173.2M in free cash flow.

Operating Activities
+$254.3M
Cash from core business operations
2025-12-31
Investing Activities
−$72.9M
CapEx, acquisitions & investments
2025-12-31
Financing Activities
−$285.7M
Buybacks, dividends & debt
2025-12-31
FCF FormulaOperating CF ($254.3M) − |CapEx| (81M) = FCF ($173.2M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement
livn cash flow statement · livn cash flow statement 2025 · livn operating cash flow · livn cash flow from operations

Free cash flow vs peers (Healthcare)

#CompanyFree Cash FlowYoY
#1
LivaNova PLC
LivaNova PLCYOU
LIVN
$173.2M+27.4%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$19.70B-0.7%
#3
AbbVie Inc.
AbbVie Inc.
ABBV
$17.82B-0.1%
#4
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$16.07B-22.4%
#5
Eli Lilly and Company
Eli Lilly and Company
LLY
$8.97B+2065.6%
Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

LivaNova PLC (LIVN) reported free cash flow of $173.2M for FY2025 (fiscal year ending 2025-12-31), up 27.4% year-over-year. The FCF margin was 12.5%.

Based on available data, LivaNova PLC has maintained positive free cash flow for at least 13 fiscal year(s). FCF peaked at $173.2M in FY2025.

LivaNova PLC's FCF yield is 3.94% and price-to-FCF ratio is 25.1x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Frequently asked questions

LIVN free cash flow · 8 questions

LivaNova PLC free cash flow was $173.2M for FY2025, up 27.4% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $161.1M.

LIVN free cash flowLIVN FCFLIVN FCF 2025LIVN free cash flow TTM

Source: FMP /cash-flow-statement · US GAAP · LivaNova PLC · LivaNova PLC SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026